IV Antiplatelet Therapy in Cardiogenic Shock and Arrest: Insights from the CAMEO Registry

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Grant Support/Research Contract - Chiesi; Abbott Vascular; Abiomed; Pfizer